This Huberman Lab podcast episode focuses on bipolar disorder (BD), differentiating between Bipolar I and Bipolar II based on the duration and intensity of manic and depressive episodes. The episode details diagnostic criteria for manic episodes, discusses the high heritability of BD, and explores various treatments including lithium (its history and mechanisms), ketamine, electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), and the potential benefits of Omega-3 fatty acids and inositol. The speaker emphasizes the importance of combining medication with talk therapies like cognitive behavioral therapy (CBT) for effective BD management, highlighting the significant maladaptive effects and high suicide risk associated with the disorder. While acknowledging a correlation between creativity and BD in certain professions, the speaker stresses the disorder's detrimental nature and the need for professional help.
